CIMA LABS' DuraSolv Fast-Dissolve Oral Drug Delivery System Awarded Second U.S. Patent.Business Editors & Medical Writers MINNEAPOLIS--(BUSINESS WIRE)--May 29, 2001 CIMA LABS, INC inc - /ink/ increment, i.e. increase by one. Especially used by assembly programmers, as many assembly languages have an "inc" mnemonic. Antonym: dec. . (Nasdaq NMS See NetWare Management System. :CIMA) today announced the issuance of a patent (No. 6,221,392) from the U.S. Patent and Trademark Office for its DuraSolv(TM) oral drug delivery system. Patent protection will extend through 2018. The new patent, which covers a hard tablet that dissolves rapidly, is wider in scope than the initial DuraSolv patent. By eliminating the requirement for a particular tablet hardness, the new patent allows for a less restrictive manufacturing process for DuraSolv-based pharmaceuticals. DuraSolv is a complementary technology to the Company's OraSolv(R) oral drug delivery system, which combines taste-masked active drug ingredients with a fast dissolving, low effervescence ef·fer·vesce intr.v. ef·fer·vesced, ef·fer·vesc·ing, ef·fer·vesc·es 1. To emit small bubbles of gas, as a carbonated or fermenting liquid. 2. To escape from a liquid as bubbles; bubble up. 3. system, enabling tablets to dissolve quickly in the mouth without chewing chewing or mastication Up-and-down and side-to-side movements of the lower jaw, using the teeth to grind food for easier swallowing. During chewing, the tongue shapes food into a lump and saliva lubricates it for swallowing. or the need for water. In comparison to OraSolv, DuraSolv is a higher compaction, more durable fast-dissolve dosage form A dosage form is the physical form of a dose of medication, such as a capsule or injection. The route of administration is dependent on the dosage form of a given drug. that permits tablets to be packaged at higher production rates and lower costs in conventional foil pouches or bottles. An Australian Letters Patent An instrument issued by a government that conveys a right or title to a private individual or organization, including conveyances of land and inventions. Although Article I, Section 8, Clause 8, of the U.S. (No. 726336) for the DuraSolv drug delivery system was also recently issued. Corresponding to the Company's first U.S. DuraSolv patent, the Australian patent expires in 2018. About CIMA CIMA develops and manufactures prescription and over-the-counter products for pharmaceutical companies based upon its proprietary, fast-dissolve drug delivery technologies, OraSolv and DuraSolv. CIMA formulates a pharmaceutical company's active drug ingredient into a new, orally disintegrating dosage form that dissolves quickly in the mouth without chewing or the need for water. Taste masking mask·ing n. 1. The concealment or the screening of one sensory process or sensation by another. 2. An opaque covering used to camouflage the metal parts of a prosthesis. agents may be used with the Company's fast-dissolve technologies to prevent or minimize the unpleasant taste associated with many active drug ingredients. CIMA currently manufactures five pharmaceutical brands utilizing its OraSolv and DuraSolv technologies: three prescription and two over-the-counter. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion